logo

For the Inventor, By the Inventor

Drammen, Norway

Fmc Biopolymer as


USPTO Granted Patents = 25

% Expired Patents = 60.0



Forward Citations = 275

Loading Chart...
Loading Chart...

49 inventors (with patents filed for the assignee):

goldMedal Jan Egil Melvik (7 out of 8 patents)

silverMedal Michael Dornish (7 out of 8 patents)

bronzeMedal Peder Oscar Andersen (5 out of 15 patents)

4.  Terje Svendsen (5 out of 7 patents)

5.  Rolf Myrvold (4 out of 10 patents)

6.  Olav Gaserod (4 out of 10 patents)

7.  Edvar Onsoyen (4 out of 4 patents)

8.  Astrid B Berge (4 out of 4 patents)

9.  Arne Dessen (2 out of 11 patents)

10.  Kurt Ingar Draget (2 out of 14 patents)

11.  Finn Hjelland (2 out of 3 patents)

12.  Christian Klein Larsen (2 out of 9 patents)

13.  Olav Gåserød (2 out of 2 patents)

14.  Merethe Kamfjord Simensen (2 out of 2 patents)

15.  Denis Dufrane (1 out of 5 patents)


Core Competencies:
Self-Gelling Alginate
Biocompatible Coating
Gene Delivery
Polysaccharide Capsules
Cell Growth Control
Gelled Foam
Uronic Acid Blocks
High Strength Capsules
Immunostimulation
Collagen Matrix
Oligonucleotide Delivery
Alginate Matrices

25 patents:

1. 9463162 - Self-gelling alginate systems and uses thereof (2016-10-11),
2. 8809521 - Delayed self-gelling alginate systems and uses thereof (2014-08-19),
3. 8741872 - Self-gelling alginate systems and uses thereof (2014-06-03),
4. 8541017 - Use of alginate matrices to control cell growth (2013-09-24),
5. 8481695 - Self-gelling alginate systems and uses thereof (2013-07-09),
6. 8257727 - Medical devices coated with a fast dissolving biocompatible coating (2012-09-04),
7. 8168215 - Alginate coated, collagen matrix cellular device, preparative methods, and uses thereof (2012-05-01),
8. 7972620 - Polysaccharide capsules and methods of preparation (2011-07-05),
9. 7893038 - Oral immunostimulation of mammals birds and reptiles from (1-4) linked β-D-mannuronic acid (2011-02-22),
10. 7875449 - Oligonucleotide non-viral delivery systems (2011-01-25),
11. 7838641 - Process for the production of alginate having a high mannuronic acid-content (2010-11-23),
12. 7816340 - Oral immunostimulation of fish from (1-4) linked β-D-mannuronic acid (2010-10-19),
13. 7790699 - Self-gelling alginate systems and uses thereof (2010-09-07),
14. 7790193 - Use of alginate matrices to control cell growth (2010-09-07),
15. 7767456 - Non-viral gene delivery system (2010-08-03),
Company Overview
FMC Biopolymer AS, located in Drammen, Norway, specializes in the development and manufacturing of biopolymer solutions for various industries. The company focuses on creating sustainable and innovative materials that enhance product performance while minimizing environmental impact. Its expertise spans multiple sectors, including food, pharmaceuticals, and personal care, where it leverages advanced research in biopolymer technology to deliver tailored solutions that meet the evolving needs of its global clientele.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

25 Patents

#1 in Drammen

#66 in Norway

#25,710 in the World

Drammen, NO
Drammen, Norway

Fmc Biopolymer as

Forward Citations = 275

49 inventors:

goldMedal Jan Egil Melvik (7 out of 8 patents)

silverMedal Michael Dornish (7 out of 8 patents)

bronzeMedal Peder Oscar Andersen (5 out of 15 patents)

4.  Terje Svendsen (5 out of 7 patents)

5.  Rolf Myrvold (4 out of 10 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Fmc Biopolymer as. Retrieved from https://idiyas.com/company/fmc-biopolymer-as

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…